Respiratory diseases are the indications that account for more than half of the patents. It encompasses a variety of small branch illnesses in addition to asthma and COPD. For example, US20100316724 relates to the treatment and/or prevention of bronchiolitis obliterans (BO) and/or bronchiolitis ...